For: | Belgioia L, Vagge S, Agnese D, Garelli S, Murialdo R, Fornarini G, Chiara S, Gallo F, Bacigalupo A, Corvò R. Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. World J Gastroenterol 2015; 21(37): 10688-10696 [PMID: 26457030 DOI: 10.3748/wjg.v21.i37.10688] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i37/10688.htm |
Number | Citing Articles |
1 |
|
2 |
Ilaria Chiola, Liliana Belgioia, Elena M. L. Vaccara, Marco Gusinu, Renzo Corvò. Reirradiation of pulmonary artery intimal sarcoma: A case report. Clinical Case Reports 2019; 7(7): 1342 doi: 10.1002/ccr3.2216
|
3 |
Liliana Belgioia, Camilla Satragno, Gladys Blandino, Alessandra Fozza, Flavio Giannelli, Michela Marcenaro, Giulia Vidano, Federica Picichè, Francesco Lanfranchi, Alberto Tagliafico, Gianmario Sambuceti, Matteo Bauckneht, Giorgia Timon. Once-a-Week Ablative Radiotherapy as Replacement of Prolonged Fractionation in Frail Patients: Feasibility and Toxicity Results. Cancer Investigation 2024; 42(10): 893 doi: 10.1080/07357907.2024.2425729
|
4 |
D. Peiffert, A.S. Baumann, A.A. Serre, V. Vendrely, N. Rouard, J.C. Faivre, G. Vogin. Cancer du canal anal : à l’ère de la radiothérapie conformationnelle avec modulation d’intensité, questions en suspens. Cancer/Radiothérapie 2018; 22(6-7): 509 doi: 10.1016/j.canrad.2018.07.131
|
5 |
Lisa Durrant, Maxwell Robinson, Maria A. Hawkins, Frank Van den Heuvel, Rebecca Muirhead. Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT). Radiotherapy and Oncology 2016; 121(1): 92 doi: 10.1016/j.radonc.2016.08.011
|
6 |
Guillaume Klausner, Eivind Blais, Raphaël Jumeau, Julian Biau, Mailys de Meric de Bellefon, Mahmut Ozsahin, Thomas Zilli, Raymond Miralbell, Juliette Thariat, Idriss Troussier. Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy. Medical Oncology 2018; 35(10) doi: 10.1007/s12032-018-1197-1
|
7 |
Ethan B. Ludmir, Lisa A. Kachnic, Brian G. Czito. Evolution and Management of Treatment-Related Toxicity in Anal Cancer. Surgical Oncology Clinics of North America 2017; 26(1): 91 doi: 10.1016/j.soc.2016.07.004
|
8 |
Edward Christopher Dee, James D. Byrne, Jennifer Y. Wo. Evolution of the Role of Radiotherapy for Anal Cancer. Cancers 2021; 13(6): 1208 doi: 10.3390/cancers13061208
|
9 |
Theresa Obermueller, Joris Hautekiet, Maria P. Busto, Dries Reynders, Liliana Belgioia, Annemieke Cats, Duncan C. Gilbert, Stefan A. Koerber, Sabine Mai, Didier Meulendijks, Franz Rödel, Ho-Young Yhim, Svetlana Hetjens, Christel Weiß, Christina L. Rasmussen, Aivara Urbute, Freija Verdoodt, Susanne K. Kjaer, Miriam Reuschenbach, Els Goetghebeur, Magnus von Knebel Doeberitz, Marc Arbyn, Elena-Sophie Prigge. Prognostic value of high-risk human papillomavirus DNA and p16INK4a immunohistochemistry in patients with anal cancer: An individual patient data meta-analysis. European Journal of Cancer 2021; 157: 165 doi: 10.1016/j.ejca.2021.07.041
|
10 |
Daniel Martin, Panagiotis Balermpas, Ria Winkelmann, Franz Rödel, Claus Rödel, Emmanouil Fokas. Anal squamous cell carcinoma – State of the art management and future perspectives. Cancer Treatment Reviews 2018; 65: 11 doi: 10.1016/j.ctrv.2018.02.001
|
11 |
Pierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Mario Morino, Gianmauro Numico, Umberto Ricardi. Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective. Expert Review of Anticancer Therapy 2017; 17(4): 335 doi: 10.1080/14737140.2017.1288104
|